Answers are grounded in this paper and cite their sources.
Hereditary gamma globulins (Gm's) of different genetic types are detected by inhibition or non-inhibition of specific agglutination systems (e.g. Grubb and Laurell, 1956; Ropartz, Lenoir, and Rivat, 1961). Although inhibition of agglutination is similarly utilized in tests of specificity of many antigen-antibody systems, early workers considered the Gm-anti Gm reactions as nonimmunologic, and the anti-Gm agglutinators as nonspecific “reagins,” analogous to the Wasserman “reagins” (Grubb, 1958, 1961; Harboe, 1959). The evidence cited against the antigen nature of these Gm factors and the antibody character of the homologous anti-γ-globulin, included (1) lack of biologic reaction on infusion of γ-globulin into subjects possessing anti-γ-globulin agglutinators (Grubb, 1961), and on infusion of anti-γ-globulins into normal subjects (Harris and Vaughn, 1961); (2) similar survival time of injected Gm(a+) γ-globulin in patients with anti-Gm(a) as compared with normal subjects (Strassle, Alpstag, and Miescher, 1958); and (3) the presence of agglutinators only in patients with rheumatoid...
No takes yet. Share an insight, caveat, or question.
Fudenberg et al. (1964) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: